Tania H Watts

21PUBLICATIONS
76CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 17, 2026
TRAF1 S146 is constitutively phosphorylated in OP9-cultured primary chronic lymphocytic leukemia cells by PKN1/2.

|Jul 30, 2026
T cell immunity to SARS-CoV-2 vaccination in inflammatory bowel disease patients treated with anti-cytokine biologics.

|May 15, 2026
Serological Benefit of SARS-CoV-2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia.

|Nov 18, 2025
Guidelines for T cell nomenclature.

David Masopust, Amit Awasthi, Rémy Bosselut

|Jul 09, 2025
STING agonists drive recruitment and intrinsic type I interferon responses in monocytic lineage cells for optimal anti-tumor immunity.

Melanie Girard, Tianning Yu, Nathalia V Batista

|Jul 03, 2023
Considerations for Choosing T Cell Assays during a Pandemic.

Jaclyn C Law, Tania H Watts

Pageof 4

Frequent Collaborators

3 joint publications

Anne-Claude Gingras

3 joint publications

Mario Ostrowski

3 joint publications

Nathália V Batista

2 joint publications

Janna R Shapiro